Excess mortality from cardiovascular disease in patients with rheumatoid arthritis

The cardiovascular morbidity and mortality are increased in rheumatoid arthritis and probably equal those of patients with type 2 diabetes mellitus. The European League Against Rheumatism has recently provided evidence-based guidelines for cardiovascular risk management in patients with rheumatoid arthritis and we here briefly summarise these guidelines and other recent data in this area of research.

Errataetall:

CommentIn: Ugeskr Laeger. 2011 Mar 14;173(11):837; author reply 837. - PMID 21520672

Medienart:

E-Artikel

Erscheinungsjahr:

2011

Erschienen:

2011

Enthalten in:

Zur Gesamtaufnahme - volume:173

Enthalten in:

Ugeskrift for laeger - 173(2011), 5 vom: 31. Jan., Seite 343-6

Sprache:

Dänisch

Weiterer Titel:

Overdødelighed af hjerte-kar-sygdomme ved reumatoid artritis

Beteiligte Personen:

Lindhardsen, Jesper [VerfasserIn]
Gislason, Gunnar Hilmar [VerfasserIn]
Ahlehoff, Ole [VerfasserIn]
Madsen, Ole Rintek [VerfasserIn]
Hansen, Peter Riis [VerfasserIn]

Themen:

Angiotensin-Converting Enzyme Inhibitors
Antirheumatic Agents
English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 25.02.2011

Date Revised 26.04.2011

published: Print

CommentIn: Ugeskr Laeger. 2011 Mar 14;173(11):837; author reply 837. - PMID 21520672

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM205440789